Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
about
Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence.The symptomatic management of multiple sclerosis.Case Report: Two Cases of Nicolau Syndrome Associated with Glatiramer Acetate.Prevalence of cutaneous adverse events associated with long-term disease-modifying therapy and their impact on health-related quality of life in patients with multiple sclerosis: a cross-sectional studyAdvances in and Algorithms for the Treatment of Relapsing-Remitting Multiple SclerosisRecognizing nonadherence in patients with multiple sclerosis and maintaining treatment adherence in the long term.
P2860
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@ast
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@en
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@nl
type
label
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@ast
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@en
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@nl
prefLabel
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@ast
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@en
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@nl
P2093
P1476
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
@en
P2093
Catherine M Edgar
Donald G Brunet
E Vee McBride
Paul Fenton
Peter Green
P577
2004-02-01T00:00:00Z